NNNN
Anbio Biotechnology
6.10$
-3.3%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Anbio Biotechnology (NNNN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -6.7 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 4.2 | 4.4 | 0.9 | 2.1 | -6.7 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | |
| 1.6 | -5.5 | -1.2 | 0.0 | -13 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | -1.5 | 1.7 | 0.3 | -4.2 | |
| – | 0.0 | 0.0 | -0.3 | 6.9 | |
| 4.2 | 2.9 | 2.6 | 2.1 | -4.0 | |
| 4.2 | 4.4 | 0.9 | 2.1 | -6.7 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.